Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
COPENHAGEN, June 24 /PRNewswire/ --
- Summary: Genmab Initiates a Phase I/II Study of Zalutumumab in Combination With Radiotherapy for the Treatment of Advanced Head and Neck Cancer.
Genmab A/S (OMX…